Literature DB >> 5638099

The renal excretion of indomethacin and its inhibition by probenecid.

M D Skeith, P A Simkin, L A Healey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5638099     DOI: 10.1002/cpt19689189

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  24 in total

1.  The clinical significance of indomethacin-probenecid interaction.

Authors:  P M Brooks; M A Bell; R D Sturrock; J P Famaey; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  The effect of frusemide on indomethacin plasma levels.

Authors:  P M Brooks; M A Bell; P Lee; P J Rooney; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

Review 3.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

Review 4.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

5.  Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Authors:  L O Eriksson; E Wåhlin-Boll; H Liedholm; P Seideman; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

7.  Drug interactions in paediatrics.

Authors:  M L Magotra
Journal:  Indian J Pediatr       Date:  1974-06       Impact factor: 1.967

8.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 9.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 10.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.